These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32580513)

  • 1. MicroRNA-199b Downregulation Confers Resistance to 5-Fluorouracil Treatment and Predicts Poor Outcome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.
    Cristóbal I; Rubio J; Santos A; Torrejón B; Caramés C; Imedio L; Mariblanca S; Luque M; Sanz-Alvarez M; Zazo S; Madoz-Gúrpide J; Rojo F; García-Foncillas J
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32580513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of microRNA-199b as A Promising Predictor of Outcome and Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer Patients.
    Cristóbal I; Santos A; Rubio J; Caramés C; Zazo S; Sanz-Álvarez M; Luque M; Madoz-Gúrpide J; Rojo F; García-Foncillas J
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-19b Plays a Key Role in 5-Fluorouracil Resistance and Predicts Tumor Progression in Locally Advanced Rectal Cancer Patients.
    Santos A; Cristóbal I; Rubio J; Caramés C; Luque M; Sanz-Álvarez M; Zazo S; Madoz-Gúrpide J; Rojo F; García-Foncillas J
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low MicroRNA-19b Expression Shows a Promising Clinical Impact in Locally Advanced Rectal Cancer.
    Rubio J; Cristóbal I; Santos A; Caramés C; Luque M; Sanz-Alvarez M; Zazo S; Madoz-Gúrpide J; Rojo F; García-Foncillas J
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33810186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-199b Deregulation Shows Oncogenic Properties and Promising Clinical Value as Circulating Marker in Locally Advanced Rectal Cancer Patients.
    Santos A; Cristóbal I; Rubio J; Caramés C; Luque M; Sanz-Alvarez M; Morales-Gallego M; Madoz-Gúrpide J; Rojo F; García-Foncillas J
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of microRNA-199b predicts unfavorable prognosis and emerges as a novel therapeutic target which contributes to PP2A inhibition in metastatic colorectal cancer.
    Cristóbal I; Caramés C; Rincón R; Manso R; Madoz-Gúrpide J; Torrejón B; González-Alonso P; Rojo F; García-Foncillas J
    Oncotarget; 2017 Jun; 8(25):40169-40180. PubMed ID: 27517624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-199b Deregulation Shows a Strong SET-Independent Prognostic Value in Early-Stage Colorectal Cancer.
    Cristóbal I; Rubio J; Torrejón B; Santos A; Caramés C; Luque M; Sanz-Álvarez M; Alonso R; Zazo S; Madoz-Gúrpide J; Rojo F; García-Foncillas J
    J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32731550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of microRNA-199a-5p is associated with superior clinical outcomes in patients with locally advanced rectal cancer.
    Baek DW; Kim G; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Kang MK; Hur K; Kim JG
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):105-115. PubMed ID: 31781865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal Cancer.
    Caramés C; Cristobal I; Moreno V; Marín JP; González-Alonso P; Torrejón B; Minguez P; Leon A; Martín JI; Hernández R; Pedregal M; Martín MJ; Cortés D; García-Olmo D; Fernández MJ; Rojo F; García-Foncillas J
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer.
    Yu J; Li N; Wang X; Ren H; Wang W; Wang S; Song Y; Liu Y; Li Y; Zhou X; Luo A; Liu Z; Jin J
    Oncotarget; 2016 Sep; 7(39):64233-64243. PubMed ID: 27572313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of miR-199b is associated with distant metastasis in colorectal cancer via activation of SIRT1 and inhibition of CREB/KISS1 signaling.
    Shen ZL; Wang B; Jiang KW; Ye CX; Cheng C; Yan YC; Zhang JZ; Yang Y; Gao ZD; Ye YJ; Wang S
    Oncotarget; 2016 Jun; 7(23):35092-105. PubMed ID: 27145368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: a meta analysis.
    An X; Lin X; Wang FH; Goodman K; Cai PQ; Kong LH; Fang YJ; Gao YH; Lin JZ; Wan DS; Pan ZZ; Ding PR
    Eur J Cancer; 2013 Mar; 49(4):843-51. PubMed ID: 23063351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer.
    Caramés C; Cristóbal I; Moreno V; del Puerto L; Moreno I; Rodriguez M; Marín JP; Correa AV; Hernández R; Zenzola V; Hernández T; León A; Martín JI; Sánchez-Fayos P; García-Olmo D; Rojo F; Goel A; Fernandez-Aceñero MJ; García-Foncillas J
    Int J Colorectal Dis; 2015 Jul; 30(7):899-906. PubMed ID: 25953218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulation of the miR-19b/PPP2R5E Signaling Axis Shows High Functional Impact in Colorectal Cancer Cells.
    Santos A; Cristóbal I; Caramés C; Luque M; Sanz-Álvarez M; Madoz-Gúrpide J; Rojo F; García-Foncillas J
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of miR-21 to Predict Incomplete Response to Chemoradiotherapy in Rectal Adenocarcinoma.
    Ourô S; Mourato C; Velho S; Cardador A; Ferreira MP; Albergaria D; Castro RE; Maio R; Rodrigues CMP
    Front Oncol; 2020; 10():577653. PubMed ID: 33194696
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic significance of pathological response to preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Tomono A; Yamashita K; Kanemitsu K; Sumi Y; Yamamoto M; Kanaji S; Imanishi T; Nakamura T; Suzuki S; Tanaka K; Kakeji Y
    Int J Clin Oncol; 2016 Apr; 21(2):344-349. PubMed ID: 26338272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing pathological complete response rate using oral capecitabine versus infusional 5-fluorouracil with preoperative radiotherapy in rectal cancer treatment.
    Jootun N; Evans T; Mak J; Makin G; Platell C
    ANZ J Surg; 2018 Jan; 88(1-2):62-65. PubMed ID: 28982208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-552 deficiency mediates 5-fluorouracil resistance by targeting SMAD2 signaling in DNA-mismatch-repair-deficient colorectal cancer.
    Zhao P; Ma YG; Zhao Y; Liu D; Dai ZJ; Yan CY; Guan HT
    Cancer Chemother Pharmacol; 2019 Aug; 84(2):427-439. PubMed ID: 31087138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma.
    D'Angelo E; Zanon C; Sensi F; Digito M; Rugge M; Fassan M; Scarpa M; Pucciarelli S; Nitti D; Agostini M
    J Clin Pathol; 2018 Apr; 71(4):344-350. PubMed ID: 28870889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer.
    Campayo M; Navarro A; Benítez JC; Santasusagna S; Ferrer C; Monzó M; Cirera L
    PLoS One; 2018; 13(11):e0206542. PubMed ID: 30388154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.